• FirefoxTry Yahoo Finance on Firefox »
  •  Dow down 0.32% Nasdaq down 0.01%
    {"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}
     Dow down 0.32% Nasdaq down 0.01%
    {"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}

    Quote Results

    Add Quotes

    SymbolTime & PriceChg & % ChgDay's Low & HighVolumeAvg VolMkt CapChartMore Info
    No such ticker symbol: ANTHEMTry Symbol Lookup
    04:00pm EDT 165.83 +6.66 +4.18% 156.03 168.20 678,483 927,195 5.91B Sparkline Chart Chart, News, Stats, Options, Board
    No such ticker symbol: CROSSTry Symbol Lookup
    No such ticker symbol: PROVIDERTry Symbol Lookup
    04:00pm EDT 19.41 -0.32 -1.62% 19.16 19.90 42,404 60,177 204.17M Sparkline Chart Chart, News, Stats, Board
    {"s" : "blue,ancx","k" : "t53,l84,c63,p43,g53,h53,v53,j10,c63,l84,p43,a00,a50,b00,b60,g00,h00,t53,v53","o" : "","j" : "c63,l84,p43,t53,v53"}

    Quotes delayed, except where indicated otherwise.

    Recent News

    day and time symbols news headline and source
    Tuesday July 28, 2015
    The Zacks Analyst Blog Highlights: Biogen, Ligand Pharmaceuticals, bluebird bio, Regeneron Pharmaceuticals and Exelixis - Press Releases Zacks09:30am EDT
    Monday July 27, 2015
    Forget Biogen, Buy These Promising Biotech Stocks Instead - Analyst Blog Zacks10:58am EDT
    Thursday July 23, 2015
    ACCESS NATIONAL CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Fin EDGAR Online04:53pm EDT
    Wednesday July 22, 2015
    Why You Shouldn't Bet Against Access National (ANCX) Stock - Tale of the Tape Zacks08:47am EDT
    Sunday July 19, 2015
    What's in bluebird bio's Pipeline That Has Investors So Excited? at Motley Fool10:02am EDT
    Friday July 17, 2015
    Access National posts 2Q profit AP06:51am EDT
    Access National Declares Dividend, Reports Second Quarter Earnings Business Wire06:45am EDT
    Wednesday July 15, 2015
    Here are the other immunotherapy companies Juno investors have their eyes on at American City Business Journals05:15pm EDT
    Wednesday July 8, 2015
    Why Shares in Bluebird Bio Slumped By More Than 10% in June at Motley Fool09:41am EDT
    Monday July 6, 2015
    BLUEBIRD BIO, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online08:01am EDT
    Thursday July 2, 2015
    Kite Pharma Gains after Striking KTE-C19 Development Deal - Analyst Blog Zacks05:00pm EDT
    Tuesday June 30, 2015
    Juno-Celgene Deal Has Street Cautiously Optimistic at Investor's Business Daily04:58pm EDT
    Celgene bet $1 billion that this biotech’s science can cure deadly cancers at Fortune04:02pm EDT
    Wednesday June 24, 2015
    BLUEBIRD BIO, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements EDGAR Online04:44pm EDT
    Kite Pharma Shares Its Vision: Here's How Wall Street Is Reacting Benzinga12:15pm EDT
    Kite Pharma CEO: Targeting cancer cells CNBC07:52am EDT
    Inside Kite Pharma's 100% run CNBC07:51am EDT
    Tuesday June 23, 2015
    bluebird bio Announces Pricing of Public Offering of Common Stock Business Wire09:27pm EDT
    Biotech IPOs Steam Ahead Despite Fears Of Overload at Investor's Business Daily05:56pm EDT
    After-hours buzz: Netflix, Boeing, Sysco & more at CNBC05:42pm EDT
    bluebird bio Announces Proposed Public Offering of Common Stock Business Wire04:01pm EDT
    Kite Pharma and Bluebird Tie Up for HPV Cancer Targets - Analyst Blog Zacks10:00am EDT
    Monday June 22, 2015
    Kite Pharma, Bluebird Bio Team Up To Fight HPV at Investor's Business Daily11:14am EDT
    BLUEBIRD BIO, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online08:31am EDT
    Kite Pharma and bluebird bio Announce Strategic Collaboration to Advance Second Generation TCR Cell Therapy Products to Treat HPV-Associated Cancers GlobeNewswire08:00am EDT